References
- Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999;93:3167–3215.
- Sanz M. Treatment of acute promyelocytic leukemia. Hematology Am Soc Hematol Educ Program 2006;147–155.
- Clarke N, Germain P, Altucci L, Gronemeyer H. Retinoids: potential in cancer prevention and therapy. Expert Rev Mol Med 2004;6:1–23.
- Fernandez-Mateos A, Mateos Buron L, Martin de la Nava EM, Rubio Gonzalez R. Synthesis of CDE and BCDE molecular fragments of the limonoids havanensin and azadiradione. J Org Chem 2003;68:3585–3592.
- Rosenberger M, Neukom C, Rosenberger M, Neukom C. Retinoic acid metabolites. 2. Total synthesis of rac-(2E,4E,6E,8E)-3,7-dimethyl-9-(6-carboxy-2,6-dimethyl-3-oxo-1-cyclohexen-1-yl)- 2,4,6,8-nonatetraenoic acid and rac-(2E,4E,6E,8E)-3,7-dimethyl-9-[2,6-dimethyl-6-(hydroxymethyl)- 3-oxo-1-cyclohexen-1-yl]- 2,4,6,8-nonatetraenoic acid. J Org Chem 1982;47:1779–1782.
- Waugh KM, Berlin KD, Ford WT, et al Synthesis and characterization of selected heteroarotinoids. Pharmacological activity as assessed in vitamin A deficient hamster tracheal organ cultures. Single-crystal X-ray diffraction analysis of 4,4-dimethylthiochroman-6-yl methyl ketone 1,1-dioxide and ethyl(E)-p-[2-(4,4-dimethylthiochroman-6-yl)propenyl]benzoate. J Med Chem 1985;28:116–124.
- Das B, Kabalka G. Design and synthesis of (E)- 4-((3-ethyl-2,4,4-trimethylcyclohex-2-enylidene)methyl)benzoic acid. Tetrahedron Lett 2008;49:4695.
- Um SJ, Kwon YJ, Han HS, et al Synthesis and biological activity of novel retinamide and retinoate derivatives. Chem Pharm Bull 2004;52:501–506.
- Minucci S, Zand DJ, Dey A, et al Dominant negative retinoid X receptor beta inhibits retinoic acid-responsive gene regulation in embryonal carcinoma cells. Mol Cell Biol 1994;14:360–372.
- Alsayed Y, Uddin S, Mahmud N, et al Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem 2001;276:4012–4019.
- Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 1995;375:377–382.
- Klaholz BP, Mitschler A, Moras D. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. J Mol Biol 2000;302:155–170.
- Pogenberg V, Guichou JF, Vivat-Hannah V, et al Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies. J Biol Chem 2005;280:1625–1633.
- Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell 2000;5:289–298.
- Teng M, Duong TT, Klein ES, Pino ME, Chandraratna RA. Identification of a retinoic acid receptor alpha subtype specific agonist. J Med Chem 1996;39:3035–3038.
- Miwako I, Kagechika H. Tamibarotene. Drugs Today 2007;43:563–568.
- Ohnishi K. PML-RAR alpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Int J Clin Oncol 2007;12:313–317.
- de Lera AR, Bourguet W, Altucci L, Gronemeyer H. Design of selective nuclear receptor modulators: RAR and RXR as a case study. Nat Rev Drug Discov 2007;6:811–820.
- Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 2004;3:950–964.
- Lu XP, Fanjul A, Picard N, et al Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat Med 1997;3:686–690.
- Cincinelli R, Dallavalle S, Nannei R, et al Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-4-ylacrylic acids endowed with antiproliferative and proapoptotic activity. J Med Chem 2005;48:4931–4946.
- Holmes WF, Soprano DR, Soprano KJ. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines. J Cell Physiol 2004;199:317–329.
- Xu QH, Konta T, Furusu A, et al Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids – selective roles of nuclear receptors and contribution to the antiapoptotic effect. J Biol Chem 2002;277:41693–41700.
- Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med 2001;7:680–686.